Log In
CQMS
Make a Donation
Log In
Donate
Donate
TROG 2026 ASM: Register now to join us in Melbourne in March
How TROG's Emerging Investigators group is supporting new researchers
2026 Clinical Research Education Workshop (CREW) - Virtual attendance now available
Apply for free virtual CREW places for rural, regional & remote participants .
Notice of AGM of the Trans Tasman Radiation Oncology Group .

ANZLG HD3/TROG 99.01 – Hodgkins Disease IFRT – HD3

Completed
Lymphoma

An ANZLG / TROG Prospective Study of Limited Chemotherapy and Involved Field Radiotherapy for Patients With Clinical Stage I-II Hodgkin’s Disease

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 99.02 – Anal Canal

Next Post

TROG 98.06 – Oesophagus

Related Post

Roland Towning, participant in TROG NINJA trial
3 February, 2026

Roland’s story

Roland TowningPort Stephens, NSW Roland Towning is taking part

27 January, 2026

New guidelines developed by TROG for clinical trial use of stereotactic radiosurgery for brain metastases

LATEST NEWS: 27 January 2026 New guidelines to ensure